Literature DB >> 6287050

Successful arterial embolization of an insulinoma.

T J Moore, L M Peterson, D P Harrington, R J Smith.   

Abstract

A 38-year-old woman had fasting hypoglycemia, hyperinsulinemia, and an arteriographically demonstrable insulinoma. One year after surgical resection, however, hypoglycemia recurred and an arteriogram demonstrated a recurrent intrapancreatic vascular mass. Because of anticipated complications of another surgical approach, we elected to embolize the tumor arteriographically, using microfibrillar collagen. The patient's fasting blood glucose and insulin levels improved rapidly. Eleven months after embolization, the patient remains well, with normal blood glucose levels.

Entities:  

Mesh:

Year:  1982        PMID: 6287050

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  5 in total

1.  Embolization of nonliver visceral tumors.

Authors:  Paul G Thacker; Jeremy L Friese; Matthew Loe; Peter Biegler; Michael Larson; James Andrews
Journal:  Semin Intervent Radiol       Date:  2009-09       Impact factor: 1.513

Review 2.  Diagnosis and management of insulinoma.

Authors:  Takehiro Okabayashi; Yasuo Shima; Tatsuaki Sumiyoshi; Akihito Kozuki; Satoshi Ito; Yasuhiro Ogawa; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 3.  Non-surgical ablative therapies for inoperable benign insulinoma.

Authors:  C Mele; A Brunani; B Damascelli; V Tichà; L Castello; G Aimaretti; M Scacchi; P Marzullo
Journal:  J Endocrinol Invest       Date:  2017-07-28       Impact factor: 4.256

4.  Treatment of Insulinomas by Laparoscopic Radiofrequency Ablation: Case Reports and Literature Review.

Authors:  Changyu Yao; Xiangtao Wang; Yongli Zhang; Jian Kong; Jun Gao; Shan Ke; Xuemei Ding; Zonghai Xin; Wenlei Xu; Shaohong Wang; Wenbing Sun
Journal:  Open Med (Wars)       Date:  2020-02-11

5.  Occult insulinoma with treatment refractory, severe hypoglycaemia in multiple endocrine neoplasia type 1 syndrome; difficulties faced during diagnosis, localization and management; a case report.

Authors:  Rasika Ranaweerage; Shehan Perera; Harsha Sathischandra
Journal:  BMC Endocr Disord       Date:  2022-03-16       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.